Dr. Johnathan Moreno speaks with host Dr. Maurie Pickard about this year’s ground breaking research in the reprogramming of skin cells to act like stem cells. They also discuss the need for new embryonic cell lines that continue to be the gold standard. Continued progress in this area of research, however, is likely to be slowed due to the denial of federal funds, preventing the institution of guidelines of the National Institute of Health to facilitate the wide and rapid exchange of laboratory discoveries.
Reprogamming Skin Cells to Act Like Stem Cells
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. Johnathan Moreno speaks with host Dr. Maurie Pickard about this year’s ground breaking research in the reprogramming of skin cells to act like stem cells. They also discuss the need for new embryonic cell lines that continue to be the gold standard. Continued progress in this area of research, however, is likely to be slowed due to the denial of federal funds, preventing the institution of guidelines of the National Institute of Health to facilitate the wide and rapid exchange of laboratory discoveries.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Level Up Your Skills: Tailoring Management of HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
FINE-HEART Pooled Analysis
NYHA FC and Finerenone Response: Clinical Trial Insights
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?